In a significant move aimed at combating the ongoing opioid epidemic, the U.S. Food and Drug Administration (FDA) has announced major ...

The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

Republican lawmakers on the committee, who nearly unanimously voted against the measure, voiced concern about the centers’ ...

The FDA hopes education and legal action against 7-OH products will help prevent a second opioid crisis in the US.

Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's ...

The FDA is requiring opioid pain medication manufacturers to update safety labeling with a stronger emphasis on risks from long-term use, including addiction and overdose death.

Launched in July 2024, a north shore drug task force has seen a growing collaboration among law enforcement agencies and an ...

The U.S. Food and Drug Administration plans to require new labels on all opioid pain medications that emphasizes long-term ...

The City Council's Public Safety Committee heard about opioid trends and potential solutions to the drug crisis during a ...

Dr. Stephanie Stewart discusses opioid usage in Colorado, and what the treatment process looks like for patients struggling with opioid addiction.

A powerful new synthetic opioid, up to 1000 times stronger than morphine, has emerged in Adelaide’s street drug supply, and ...

Spokane County is moving forward with a significant expansion of its addiction and behavioral health services. The county ...